Page last updated: 2024-08-18

cyclohexanol and Drug Withdrawal Symptoms

cyclohexanol has been researched along with Drug Withdrawal Symptoms in 77 studies

Research

Studies (77)

Timeframe	Studies, this research(%)	All Research%
pre-1990	5 (6.49)	18.7374
1990's	19 (24.68)	18.2507
2000's	40 (51.95)	29.6817
2010's	13 (16.88)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abdullah, R; Cravatt, BF; Kinsey, SG; Lichtman, AH; Ramesh, D; Selley, DE; Wise, LE	1
Damaj, MI; Ignatowska-Jankowska, BM; Lichtman, AH; Muldoon, PP	1
Greenberg, H; Wang, J	1
Stevens, AW; Tak, LM	1
Groot, PC	1
Buckley, G; Khan, A; Messig, M; Musgnung, J; Ninan, PT; Ramey, T	1
Bisaga, A; Glass, A; Kelly, MA; Levin, FR; Mariani, JJ; Nunes, EV; Pavlicova, M; Sullivan, MA	1
France, CP; Gerak, LR	1
Anderson, IM; Haddad, PM; Tint, A	1
Jureidini, J; Mintzes, B	1
Kaplan, P; Kora, K	1
Kodaka, F; Koga, M; Miyata, H; Nakayama, K	1
Fava, M; Guico-Pabia, CJ; Montgomery, SA; Padmanabhan, SK; Tourian, KA	1
Andersen, CL; Videbech, P	1
McMahon, LR; Stewart, JL	1
Seywert, AJ	1
Rakun, R; Ružić, K; Sabljić, V	1
Almela, P; Aracil-Fernández, A; Manzanares, J	1
Koerselman, GF; van Noorden, MS; Vergouwen, AC	1
Ninan, PT	1
Manzanares, J; Oliva, JM; Ortiz, S; Palomo, T	2
Beddingfield, JJ; Mack, JE; Reeves, RR	1
Fava, GA; Mangelli, L	1
Chakrabarti, S; Jhirwal, OP	1
Baboolal, NS	1
Hsiao, MC; Liu, CY	2
Beyazyürek, M; Celik, T; Kayir, H; Sağlam, E; Uzbay, IT	1
Dunewicz, M; Grégoire, G; Précourt, A; Williamson, DR	1
Liappas, J; Paparrigopoulos, T; Rabavilas, A; Tzavellas, E	1
Berger, M; Feige, B; Nissen, C; Nofzinger, E; Riemann, D; Voderholzer, U	1
Aronow, WS; Beck, G; Ness, J	1
Burt, T; D'Souza, RF; George, T; Hopwood, M; Lam, W; Martin, AJ; Sir, A; Uguz, S; Vahip, S	1
Baldwin, DS; Lader, M; Montgomery, SA; Nil, R	1
Anderson, C; Baile, W; Cinciripini, L; Cinciripini, PM; de Moor, C; Lam, C; Minna, JD; Tsoh, JY; Wetter, DW	1
Campagne, DM	1
Liau, CH; Shen, WW; Su, KP	1
Connolly, A; Stewart, S; Taylor, D	1
Cooper, TB; Hungund, BL; Vinod, KY; Xie, S; Yalamanchili, R	1
Austin, MP; Bolisetty, S; Oei, J; Pakalapati, RK	1
Christodoulou, C; Douzenis, A; Lykouras, L; Michopoulos, I	1
Chen, TT; Cinciripini, PM; Lam, CY; Minna, JD; Minnix, JA; Robinson, JD; Tomlinson, GE; Wetter, DW	1
Feldman, MD; Stone, TE; Swanson, C	1
Khazaal, Y	1
Ball, S; Detke, M; Dinkel, J; Dunayevich, E; Erickson, J; Hartford, J; Kornstein, S; Liebowitz, M; Pigott, T; Russell, J; Walker, D	1
Chen, JC; Chiang, YC	1
Spindler, PE	1
de Pisa, E; Girardi, P; Kotzalidis, GD; Patrizi, B; Ruberto, G; Savoja, V	1
Farah, A; Lauer, TE	1
Benazzi, F	2
Kirsch, MA; Lannon, RA; Lewis, TB; Louie, AK	1
Gitlin, MJ	1
Kolecki, P	1
Adès, J; Lejoyeux, M	1
Haddad, P	1
Wolfe, RM	1
Mitchell, S; Tracy, KA; Zajecka, J	1
Agelink, MW; Klieser, E; Zitzelsberger, A	1
Alpert, J; Fava, M; Mulroy, R; Nierenberg, AA; Rosenbaum, JF	1
Blennerhassett, J; Parker, G	1
Macbeth, R; Rajagopalan, M	1
Chouinard, G; Dallal, A	1
Boyd, IW	1
Bouman, WP; Johnson, H; Lawton, J	1
Raby, WN	1
Aparicio Jabalquinto, G; Barriochoa Martínez de Pisón, C; Ortega García, A; Raigal Martín, Y; Sierra Santos, L	1
Abbar, M; Blayac, JP; Giniès, E; Peyrière, H; Pinzani, V; Robert, L	1
Jacob, C; Luckhaus, C	1
Ge, X; Lu, L; Ma, L; Pei, G; Su, F; Su, WJ; Yue, W	1
Devarajan, S; Dursun, SM; Haddad, PM	1
Arend, I; Cogal, A; Flohé, L; Richter, W; Simon, W	1
Yanagita, T	1
Endo, N; Kudo, Y; Masuda, Y; Murano, T; Okada, N; Yamamoto, H; Yano, I	1
Barth, H; Flohé, L; Giertz, H; Richter, W	1
Hayano, T; Masuda, Y; Murano, T; Yamamoto, H	1

Reviews

8 review(s) available for cyclohexanol and Drug Withdrawal Symptoms

Article	Year
Discontinuation symptoms in depression and anxiety disorders. The international journal of neuropsychopharmacology, 2007, Volume: 10, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety Disorders; Citalopram; Cyclohexanols; Depressive Disorder, Major; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Paroxetine; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Withholding Treatment	2007
Venlafaxine and serious withdrawal symptoms: warning to drivers. MedGenMed : Medscape general medicine, 2005, Jul-06, Volume: 7, Issue:3 Topics: Adult; Automobile Driving; Cyclohexanols; Female; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	2005
Antidepressant discontinuation: a review of the literature. The Journal of clinical psychiatry, 1997, Volume: 58 Suppl 7 Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Fluoxetine; Humans; Incidence; Monoamine Oxidase Inhibitors; Paroxetine; Recurrence; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Syndrome; Venlafaxine Hydrochloride	1997
Newer antidepressants and the discontinuation syndrome. The Journal of clinical psychiatry, 1997, Volume: 58 Suppl 7 Topics: Adverse Drug Reaction Reporting Systems; Cyclohexanols; Dizziness; Fluoxetine; Headache; Humans; Incidence; Nausea; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sleep Stages; Substance Withdrawal Syndrome; Syndrome; Venlafaxine Hydrochloride	1997
Antidepressant withdrawal reactions. American family physician, 1997, Volume: 56, Issue:2 Topics: Adult; Amitriptyline; Antidepressive Agents; Antidepressive Agents, Tricyclic; Clomipramine; Cyclohexanols; Drug Administration Schedule; Female; Humans; Male; Monoamine Oxidase Inhibitors; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Trazodone; Venlafaxine Hydrochloride	1997
Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review. The Journal of clinical psychiatry, 1997, Volume: 58, Issue:7 Topics: 1-Naphthylamine; Adolescent; Adult; Child; Clinical Trials as Topic; Cyclohexanols; Dizziness; Female; Fluoxetine; Fluvoxamine; Headache; Humans; Infant; Infant, Newborn; Male; MEDLINE; Mental Disorders; Middle Aged; Nausea; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sensation Disorders; Sertraline; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	1997
[Venlafaxine and its discontinuation syndrome]. Atencion primaria, 1999, Volume: 24, Issue:10 Topics: Adult; Antidepressive Agents, Second-Generation; Attention; Cyclohexanols; Dose-Response Relationship, Drug; Female; Humans; Memory Disorders; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride; Visual Acuity	1999
[Venlafaxine withdrawal syndrome: report of six cases and review of the literature]. La Revue de medecine interne, 2000, Volume: 21, Issue:3 Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Fatigue; Female; Gastrointestinal Diseases; Hallucinations; Headache; Humans; Male; Middle Aged; Paresthesia; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Time Factors; Venlafaxine Hydrochloride	2000

Trials

12 trial(s) available for cyclohexanol and Drug Withdrawal Symptoms

Article	Year
Abrupt discontinuation compared with a 1-week taper regimen in depressed outpatients treated for 24 weeks with desvenlafaxine 50 mg/d. Journal of clinical psychopharmacology, 2014, Volume: 34, Issue:3 Topics: Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Double-Blind Method; Drug Administration Schedule; Humans; Outpatients; Substance Withdrawal Syndrome	2014
Do withdrawal-like symptoms mediate increased marijuana smoking in individuals treated with venlafaxine-XR? Drug and alcohol dependence, 2014, Nov-01, Volume: 144 Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Marijuana Smoking; Middle Aged; Substance Withdrawal Syndrome; Treatment Outcome; Venlafaxine Hydrochloride	2014
The effect of rate of antidepressant tapering on the incidence of discontinuation symptoms: a randomised study. Journal of psychopharmacology (Oxford, England), 2008, Volume: 22, Issue:3 Topics: Adult; Analysis of Variance; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Female; Half-Life; Humans; Male; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Suicide; Venlafaxine Hydrochloride	2008
Mirtazapine and venlafaxine in the management of collateral psychopathology during alcohol detoxification. Progress in neuro-psychopharmacology & biological psychiatry, 2005, Volume: 29, Issue:1 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Anxiety; Central Nervous System Depressants; Cyclohexanols; Depressive Disorder; Ethanol; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Patient Dropouts; Psychiatric Status Rating Scales; Socioeconomic Factors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	2005
Randomized trial of sertraline versus venlafaxine XR in major depression: efficacy and discontinuation symptoms. The Journal of clinical psychiatry, 2005, Volume: 66, Issue:10 Topics: Adult; Ambulatory Care; Blood Pressure; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Female; Health Status; Humans; Male; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Substance Withdrawal Syndrome; Treatment Outcome; Venlafaxine Hydrochloride	2005
Combined effects of venlafaxine, nicotine replacement, and brief counseling on smoking cessation. Experimental and clinical psychopharmacology, 2005, Volume: 13, Issue:4 Topics: Administration, Cutaneous; Antidepressive Agents, Second-Generation; Counseling; Cyclohexanols; Diarrhea; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Female; Headache; Humans; Male; Middle Aged; Nausea; Nicotine; Nicotinic Agonists; Patient Selection; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder; Treatment Outcome; Venlafaxine Hydrochloride	2005
The DRD2 TaqI-B polymorphism and its relationship to smoking abstinence and withdrawal symptoms. The pharmacogenomics journal, 2007, Volume: 7, Issue:4 Topics: Administration, Cutaneous; Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Double-Blind Method; Female; Gene Frequency; Genotype; Homozygote; Humans; Linkage Disequilibrium; Male; Middle Aged; Nicotine; Nicotinic Agonists; Phenotype; Polymorphism, Genetic; Receptors, Dopamine D2; Severity of Illness Index; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Venlafaxine Hydrochloride	2007
Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trial. International clinical psychopharmacology, 2007, Volume: 22, Issue:3 Topics: Adult; Anxiety Disorders; Cyclohexanols; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Personality Inventory; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride	2007
Emergence of adverse events following discontinuation of treatment with extended-release venlafaxine. The American journal of psychiatry, 1997, Volume: 154, Issue:12 Topics: Adult; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Female; Humans; Male; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	1997
Withdrawal and rebound symptoms associated with abrupt discontinuation of venlafaxine. Journal of clinical psychopharmacology, 1998, Volume: 18, Issue:4 Topics: Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Recurrence; Substance Withdrawal Syndrome; Treatment Outcome; Venlafaxine Hydrochloride	1998
[Clinical study on the development of dependency after long-term treatment with tramadol (author's transl)]. Arzneimittel-Forschung, 1978, Volume: 28, Issue:1a Topics: Analgesics; Clinical Trials as Topic; Cyclohexanols; Humans; Naloxone; Pain; Placebos; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors	1978
Clinical investigation on the development of dependence during oral therapy with tramadol. Arzneimittel-Forschung, 1985, Volume: 35, Issue:11 Topics: Administration, Oral; Adult; Aged; Cyclohexanols; Double-Blind Method; Drug Administration Schedule; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Naloxone; Pain; Precipitin Tests; Random Allocation; Substance Withdrawal Syndrome; Substance-Related Disorders; Tramadol	1985

Other Studies

57 other study(ies) available for cyclohexanol and Drug Withdrawal Symptoms

Article	Year
Repeated low-dose administration of the monoacylglycerol lipase inhibitor JZL184 retains cannabinoid receptor type 1-mediated antinociceptive and gastroprotective effects. The Journal of pharmacology and experimental therapeutics, 2013, Volume: 345, Issue:3 Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arachidonic Acids; Benzodioxoles; Brain Chemistry; Cyclohexanols; Diclofenac; Dose-Response Relationship, Drug; Dronabinol; Drug Tolerance; Endocannabinoids; Glycerides; Guanosine 5'-O-(3-Thiotriphosphate); Male; Mice; Mice, Inbred C57BL; Monoacylglycerol Lipases; Pain Measurement; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Stomach Ulcer; Substance Withdrawal Syndrome; Substance-Related Disorders	2013
The cannabinoid CB2 receptor is necessary for nicotine-conditioned place preference, but not other behavioral effects of nicotine in mice. Psychopharmacology, 2013, Volume: 229, Issue:4 Topics: Animals; Anisoles; Behavior, Animal; Cocaine; Conditioning, Psychological; Cyclohexanols; Dose-Response Relationship, Drug; Female; Male; Mecamylamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Nicotine; Receptor, Cannabinoid, CB2; Reward; Substance Withdrawal Syndrome; Tobacco Use Disorder	2013
Status cataplecticus precipitated by abrupt withdrawal of venlafaxine. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2013, Jul-15, Volume: 9, Issue:7 Topics: Aged; Cataplexy; Cyclohexanols; Electroencephalography; Female; Humans; Hypertension; Narcolepsy; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	2013
[Development of (hypo)mania during discontinuation of venlafaxine in two patients with bipolar disorder]. Tijdschrift voor psychiatrie, 2013, Volume: 55, Issue:10 Topics: Bipolar Disorder; Cyclohexanols; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Treatment Outcome; Venlafaxine Hydrochloride	2013
[Taperingstrips for paroxetine and venlafaxine]. Tijdschrift voor psychiatrie, 2013, Volume: 55, Issue:10 Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Feasibility Studies; Humans; Paroxetine; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	2013
Combined Treatment with Morphine and Δ9-Tetrahydrocannabinol in Rhesus Monkeys: Antinociceptive Tolerance and Withdrawal. The Journal of pharmacology and experimental therapeutics, 2016, Volume: 357, Issue:2 Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Analgesics, Opioid; Animals; Benzoxazines; Cannabinoid Receptor Agonists; Cyclohexanols; Dose-Response Relationship, Drug; Dronabinol; Drug Tolerance; Heart Rate; Macaca mulatta; Morphine; Morpholines; Naphthalenes; Opioid-Related Disorders; Pain Measurement; Substance Withdrawal Syndrome	2016
Does venlafaxine maintenance therapy prevent depression recurrences or drug discontinuation reactions? The Journal of clinical psychiatry, 2008, Volume: 69, Issue:5 Topics: Cyclohexanols; Depressive Disorder, Major; Humans; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	2008
[Hypomania/mania induced by cessation of antidepressant drugs]. Turk psikiyatri dergisi = Turkish journal of psychiatry, 2008,Fall, Volume: 19, Issue:3 Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	2008
Symptoms of delusion: the effects of discontinuation of low-dose venlafaxine. Acta psychiatrica Scandinavica, 2009, Volume: 120, Issue:4 Topics: Adult; Clomipramine; Cyclohexanols; Delusions; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Female; Humans; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	2009
Discontinuation symptoms and taper/poststudy-emergent adverse events with desvenlafaxine treatment for major depressive disorder. International clinical psychopharmacology, 2009, Volume: 24, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome	2009
[Discontinuation of antidepressant serotonergic antidepressant]. Ugeskrift for laeger, 2010, Jan-25, Volume: 172, Issue:4 Topics: Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Depressive Disorder; Diagnosis, Differential; Female; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	2010
Rimonabant-induced Delta9-tetrahydrocannabinol withdrawal in rhesus monkeys: discriminative stimulus effects and other withdrawal signs. The Journal of pharmacology and experimental therapeutics, 2010, Volume: 334, Issue:1 Topics: Adrenergic Agonists; Animals; Behavior, Animal; Benzoxazines; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Clonidine; Cyclohexanols; Discrimination, Psychological; Dronabinol; Female; Heart Rate; Macaca mulatta; Male; Morpholines; Motor Activity; Naphthalenes; Piperidines; Pyrazoles; Rimonabant; Substance Withdrawal Syndrome	2010
[A painful weaning]. Revue medicale suisse, 2010, Jun-23, Volume: 6, Issue:254 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Female; Humans; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	2010
Venlafaxine withdrawal syndrome. Psychiatria Danubina, 2011, Volume: 23, Issue:1 Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Diagnosis, Differential; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Ischemic Attack, Transient; Retreatment; Stroke; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	2011
Pregabalin and topiramate regulate behavioural and brain gene transcription changes induced by spontaneous cannabinoid withdrawal in mice. Addiction biology, 2013, Volume: 18, Issue:2 Topics: Analysis of Variance; Animals; Anticonvulsants; Anxiety; Behavior, Animal; Body Temperature; Cannabinoids; Cyclohexanols; Dose-Response Relationship, Drug; Drug Tolerance; Fructose; gamma-Aminobutyric Acid; Male; Marijuana Abuse; Mice; Models, Animal; Motor Activity; Nucleus Accumbens; Pregabalin; Receptor, Cannabinoid, CB1; Receptors, Opioid, mu; Substance Withdrawal Syndrome; Topiramate; Transcription, Genetic; Tyrosine 3-Monooxygenase; Ventral Tegmental Area	2013
[Delirium during withdrawal of venlafaxine]. Nederlands tijdschrift voor geneeskunde, 2002, Jun-29, Volume: 146, Issue:26 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Delirium; Depression; Drug Administration Schedule; Half-Life; Humans; Male; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	2002
Pharmacokinetically induced benzodiazepine withdrawal. Psychopharmacology bulletin, 2001,Autumn, Volume: 35, Issue:4 Topics: Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Drug Interactions; Female; Humans; Middle Aged; Panic Disorder; Piperazines; Substance Withdrawal Syndrome; Triazoles; Venlafaxine Hydrochloride	2001
Behavioural and gene transcription alterations induced by spontaneous cannabinoid withdrawal in mice. Journal of neurochemistry, 2003, Volume: 85, Issue:1 Topics: Animals; Autoradiography; Behavior, Animal; Benzoxazines; Binding, Competitive; Body Temperature; Brain; Cannabinoids; Corticosterone; Cyclohexanols; Disease Models, Animal; Drug Tolerance; Enkephalins; Exploratory Behavior; Guanosine 5'-O-(3-Thiotriphosphate); Male; Mice; Morpholines; Motor Activity; Naphthalenes; Pro-Opiomelanocortin; Protein Precursors; RNA, Messenger; Substance Withdrawal Syndrome; Transcription, Genetic; Tyrosine 3-Monooxygenase	2003
Shock-like sensations during venlafaxine withdrawal. Pharmacotherapy, 2003, Volume: 23, Issue:5 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Sensation Disorders; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	2003
Mania associated with venlafaxine discontinuation. The international journal of neuropsychopharmacology, 2003, Volume: 6, Issue:1 Topics: Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Depression; Humans; Male; Middle Aged; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	2003
Venlafaxine withdrawal in organic anxiety disorder. Indian journal of medical sciences, 2003, Volume: 57, Issue:12 Topics: Adult; Anxiety Disorders; Cyclohexanols; Female; Humans; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	2003
Spontaneous cannabinoid withdrawal produces a differential time-related responsiveness in cannabinoid CB1 receptor gene expression in the mouse brain. Journal of psychopharmacology (Oxford, England), 2004, Volume: 18, Issue:1 Topics: Animals; Brain; Cannabinoids; Cyclohexanols; Drug Tolerance; Male; Mice; Motor Activity; Organ Specificity; Receptor, Cannabinoid, CB1; Substance Withdrawal Syndrome; Time Factors; Up-Regulation	2004
Venlafaxine withdrawal syndrome: report of seven cases in Trinidad. Journal of clinical psychopharmacology, 2004, Volume: 24, Issue:2 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Humans; Male; Middle Aged; Substance Withdrawal Syndrome; Trinidad and Tobago; Venlafaxine Hydrochloride	2004
Withdrawal reactions associated with low-dose venlafaxine treatment in a patient with premenstrual dysphoric disorder. The Journal of clinical psychiatry, 2004, Volume: 65, Issue:8 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	2004
Effects of venlafaxine on ethanol withdrawal syndrome in rats. Fundamental & clinical pharmacology, 2004, Volume: 18, Issue:6 Topics: Analysis of Variance; Animals; Cyclohexanols; Dose-Response Relationship, Drug; Ethanol; Male; Motor Activity; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Stereotyped Behavior; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	2004
Multiple complications and withdrawal syndrome associated with quetiapine/venlafaxine intoxication. The Annals of pharmacotherapy, 2005, Volume: 39, Issue:1 Topics: Coma; Cyclohexanols; Diagnosis, Differential; Dibenzothiazepines; Drug Overdose; Electrocardiography; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Quetiapine Fumarate; Respiratory Insufficiency; Seizures; Serotonin Agents; Serotonin Syndrome; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	2005
Transient narcolepsy-cataplexy syndrome after discontinuation of the antidepressant venlafaxine. Journal of sleep research, 2005, Volume: 14, Issue:2 Topics: Adult; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Narcolepsy; Polysomnography; Substance Withdrawal Syndrome; Treatment Failure; Venlafaxine Hydrochloride	2005
Menopausal symptoms after cessation of hormone replacement therapy. Maturitas, 2006, Feb-20, Volume: 53, Issue:3 Topics: Administration, Topical; Aged; Attitude to Health; Chi-Square Distribution; Complementary Therapies; Cyclohexanols; Estrogen Replacement Therapy; Estrogens; Female; Hot Flashes; Humans; Middle Aged; Postmenopause; Prevalence; Retrospective Studies; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	2006
Venlafaxine-associated serotonin syndrome and manic episode in a geriatric depressive patient. Psychiatry and clinical neurosciences, 2006, Volume: 60, Issue:1 Topics: Aged; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Serotonin Syndrome; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	2006
Antidepressant withdrawal symptoms-telephone calls to a national medication helpline. Journal of affective disorders, 2006, Volume: 95, Issue:1-3 Topics: Antidepressive Agents; Cyclohexanols; Hotlines; Humans; Monoamine Oxidase Inhibitors; Paroxetine; Retrospective Studies; Substance Withdrawal Syndrome; Television; United Kingdom; Venlafaxine Hydrochloride	2006
Effect of chronic ethanol exposure and its withdrawal on the endocannabinoid system. Neurochemistry international, 2006, Volume: 49, Issue:6 Topics: Amidohydrolases; Animals; Arachidonic Acids; Cannabinoid Receptor Modulators; Central Nervous System Depressants; Chromatography, Liquid; Cyclohexanols; Endocannabinoids; Ethanol; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Male; Mass Spectrometry; Mice; Polyunsaturated Alkamides; Receptor, Cannabinoid, CB1; Substance Withdrawal Syndrome; Sulfur Radioisotopes	2006
Neonatal seizures from in utero venlafaxine exposure. Journal of paediatrics and child health, 2006, Volume: 42, Issue:11 Topics: Cyclohexanols; Female; Humans; Infant, Newborn; Male; New South Wales; Pregnancy; Seizures; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	2006
Topiramate use in alprazolam addiction. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2006, Volume: 7, Issue:4 Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anticonvulsants; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Depressive Disorder, Major; Female; Fructose; Humans; Substance Withdrawal Syndrome; Substance-Related Disorders; Topiramate; Treatment Outcome; Venlafaxine Hydrochloride	2006
Venlafaxine discontinuation syndrome and suicidal ideation: a case series. Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Female; Humans; Male; Middle Aged; Substance Withdrawal Syndrome; Suicide, Attempted; Venlafaxine Hydrochloride	2007
Mania after venlafaxine withdrawal in a patient with generalized anxiety disorder. The Annals of pharmacotherapy, 2007, Volume: 41, Issue:2 Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety Disorders; Bipolar Disorder; Cyclohexanols; Humans; Male; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	2007
Successful duloxetine use to prevent venlafaxine withdrawal symptoms. Progress in neuro-psychopharmacology & biological psychiatry, 2008, Feb-15, Volume: 32, Issue:2 Topics: Adrenergic Uptake Inhibitors; Adult; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Neurotransmitter Uptake Inhibitors; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Thiophenes; Venlafaxine Hydrochloride	2008
The role of the cannabinoid type 1 receptor and down-stream cAMP/DARPP-32 signal in the nucleus accumbens of methamphetamine-sensitized rats. Journal of neurochemistry, 2007, Volume: 103, Issue:6 Topics: Amphetamine-Related Disorders; Animals; Binding, Competitive; Calcineurin; Cyclic AMP; Cyclohexanols; Dopamine and cAMP-Regulated Phosphoprotein 32; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Down-Regulation; Male; Methamphetamine; Nucleus Accumbens; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; RNA, Messenger; Signal Transduction; Substance Withdrawal Syndrome	2007
[Palinopsia following discontinuation of venlafaxine]. Psychiatrische Praxis, 2008, Volume: 35, Issue:5 Topics: Adult; Afterimage; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoxetine; Humans; Perceptual Disorders; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride; Visual Perception	2008
Similar discontinuation symptoms for withdrawal from medium-dose paroxetine and venlafaxine after nine years in the same patient. Journal of psychopharmacology (Oxford, England), 2008, Volume: 22, Issue:5 Topics: Adult; Cyclohexanols; Female; Humans; Marijuana Smoking; Paroxetine; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	2008
Possible venlafaxine withdrawal syndrome. The American journal of psychiatry, 1996, Volume: 153, Issue:4 Topics: Adult; Cyclohexanols; Depressive Disorder; Fatigue; Female; Gastrointestinal Diseases; Headache; Humans; Nausea; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Tinnitus; Venlafaxine Hydrochloride	1996
Venlafaxine withdrawal symptoms. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1996, Volume: 41, Issue:7 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Drug Administration Schedule; Dysthymic Disorder; Humans; Male; Phobic Disorders; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	1996
Venlafaxine withdrawal reactions. The American journal of psychiatry, 1996, Volume: 153, Issue:12 Topics: Cyclohexanols; Depressive Disorder; Dizziness; Female; Humans; Male; Middle Aged; Nausea; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	1996
Venlafaxine, monoamine oxidase inhibitors, and the serotonin syndrome. Journal of clinical psychopharmacology, 1997, Volume: 17, Issue:1 Topics: Adult; Bipolar Disorder; Cyclohexanols; Dose-Response Relationship, Drug; Humans; Male; Monoamine Oxidase Inhibitors; Myoclonus; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Selegiline; Substance Withdrawal Syndrome; Syndrome; Venlafaxine Hydrochloride	1997
Venlafaxine induced serotonin syndrome occurring after abstinence from phenelzine for more than two weeks. Journal of toxicology. Clinical toxicology, 1997, Volume: 35, Issue:2 Topics: Adult; Cyclohexanols; Drug Administration Schedule; Humans; Male; Phenelzine; Selective Serotonin Reuptake Inhibitors; Serotonin; Substance Withdrawal Syndrome; Syndrome; Venlafaxine Hydrochloride	1997
Dangerous interaction with nefazodone added to fluoxetine, desipramine, venlafaxine, valproate and clonazepam combination therapy. Journal of psychopharmacology (Oxford, England), 1997, Volume: 11, Issue:2 Topics: Adult; Antidepressive Agents; Clonazepam; Cyclohexanols; Depressive Disorder; Desipramine; Drug Therapy, Combination; Female; Fluoxetine; Humans; Hypotension; Panic Disorder; Piperazines; Substance Withdrawal Syndrome; Triazoles; Venlafaxine Hydrochloride	1997
Withdrawal syndrome after discontinuation of venlafaxine. The American journal of psychiatry, 1997, Volume: 154, Issue:10 Topics: Age Factors; Aged; Cyclohexanols; Depressive Disorder; Female; Gastrointestinal Diseases; Headache; Humans; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	1997
Withdrawal reactions associated with venlafaxine. The Australian and New Zealand journal of psychiatry, 1998, Volume: 32, Issue:2 Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hallucinations; Humans; Male; Risk Factors; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	1998
Venlafaxine withdrawal syndrome. Australian and New Zealand journal of medicine, 1998, Volume: 28, Issue:2 Topics: Cyclohexanols; Depressive Disorder; Electroconvulsive Therapy; Humans; Male; Middle Aged; Nausea; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	1998
Venlafaxine withdrawal reactions. The Medical journal of Australia, 1998, Jul-20, Volume: 169, Issue:2 Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety; Cyclohexanols; Depression; Depressive Disorder; Dizziness; Fatigue; Female; Hallucinations; Headache; Humans; Male; Middle Aged; Nausea; Sensation Disorders; Substance Withdrawal Syndrome; Tinnitus; Venlafaxine Hydrochloride	1998
Withdrawal reaction associated with venlafaxine. BMJ (Clinical research ed.), 1998, Sep-19, Volume: 317, Issue:7161 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Humans; Male; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	1998
Treatment of venlafaxine discontinuation symptoms with ondansetron. The Journal of clinical psychiatry, 1998, Volume: 59, Issue:11 Topics: Adult; Cyclohexanols; Depressive Disorder; Female; Humans; Ondansetron; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	1998
Venlafaxine withdrawal syndrome not prevented by maprotiline, but resolved by sertraline. The international journal of neuropsychopharmacology, 2001, Volume: 4, Issue:1 Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Female; Humans; Maprotiline; Nausea; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	2001
Attenuation of morphine dependence and withdrawal in rats by venlafaxine, a serotonin and noradrenaline reuptake inhibitor. Life sciences, 2001, May-25, Volume: 69, Issue:1 Topics: Adrenergic Uptake Inhibitors; Animals; Conditioning, Psychological; Cyclohexanols; Dopamine Antagonists; Exploratory Behavior; Male; Morphine Dependence; Motor Activity; Norepinephrine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Sulpiride; Venlafaxine Hydrochloride	2001
Antidepressant discontinuation (withdrawal) symptoms presenting as 'stroke'. Journal of psychopharmacology (Oxford, England), 2001, Volume: 15, Issue:2 Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Diagnosis, Differential; Dysthymic Disorder; Female; Humans; Paroxetine; Stroke; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	2001
Drug dependence potential of 1-(m-methoxyphenyl)-2-dimethylaminomethyl)-cyclohexan-1-ol hydrochloride (tramadol) tested in monkeys. Arzneimittel-Forschung, 1978, Volume: 28, Issue:1a Topics: Analgesics; Animals; Behavior, Animal; Cyclohexanols; Female; Haplorhini; Humans; Macaca mulatta; Male; Morphine; Morphine Dependence; Self Administration; Substance Withdrawal Syndrome; Substance-Related Disorders	1978
Studies on dependence on tramadol in rats. Arzneimittel-Forschung, 1978, Volume: 28, Issue:1a Topics: Adrenal Cortex; Analgesics; Animals; Behavior, Animal; Body Weight; Cyclohexanols; Drug Tolerance; Female; Humans; Male; Morphine; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors	1978
Studies on the physical dependence of a new central analgesic; 1-(m-methoxyphenyl)-2-dimethylaminomethyl cyclohexanol (1) HCL (CG-315). Japanese journal of pharmacology, 1972, Volume: 22, Issue:5 Topics: Adrenal Glands; Alcohols; Analgesics; Animals; Body Weight; Cyclohexanes; Cyclohexanols; Depression, Chemical; Dimethylamines; Drug Tolerance; Female; Humans; Male; Morphine; Organ Size; Rats; Substance Withdrawal Syndrome; Substance-Related Disorders	1972